TLR9 and B-cell chronic lymphocytic leukemia: TLR9 expression in vitro has been linked with increased levels of CLL cell migration, while CLL patients have been found to have significantly higher plasma levels of the TLR9 ligand - unmethylated cytosine guanine dinucleotide (CpG)-DNA, compared to healthy controls (87).